miR‑29a‑3p regulates the epithelial‑mesenchymal transition via the SPARC/ERK signaling pathway in human bronchial epithelial cells

Zhang,Xiaobo; Xie,Jun; Sun,Hongmei; Wei,Qin; Nong,Guangmin

doi:10.3892/ijmm.2021.5004

miR‑29a‑3p regulates the epithelial‑mesenchymal transition via the SPARC/ERK signaling pathway in human bronchial epithelial cells

Authors:
- Xiaobo Zhang
- Jun Xie
- Hongmei Sun
- Qin Wei
- Guangmin Nong
View Affiliations

Affiliations: Pediatric Department, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region 530021, P.R. China
Published online on: July 12, 2021 https://doi.org/10.3892/ijmm.2021.5004
Article Number: 171
Copyright: © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Neutrophilic asthma (NA) is a subtype of asthma that responds poorly to corticosteroid treatment. In certain diseases, microRNA (miR)‑29a‑3p is considered to be a key regulatory molecule for remodeling of the extracellular matrix. However, the effect of miR‑29a‑3p on airway remodeling is unknown. The present study aimed to investigate the role of miR‑29a‑3p in NA. A mouse model of NA was established and these animals were compared to normal controls. Both groups of mice were subjected to lung function tests and histopathological analysis. Human bronchial epithelial cells (16HBE) were grown in culture and incubated with secreted protein acidic rich in cysteine (SPARC) and a miR‑29a‑3p mimic. The expression of miR‑29a‑3p, SPARC and epithelial‑mesenchymal transition (EMT)‑related markers were measured using reverse transcription‑quantitative PCR and western blotting. Luciferase reporter assay was performed to identify the direct regulatory relationship between miR‑29a‑3p and SPARC. miR‑29a‑3p expression was significantly decreased, while SPARC expression was increased in the NA mouse model with a phenotype of EMT. Overexpression of SPARC downregulated the expression of E‑cadherin, while it increased the expression of vimentin in 16HBE cells. miR‑29a‑3p administration reversed the SPARC‑induced effects on E‑cadherin and vimentin expression. Luciferase assays confirmed that SPARC was the target gene for miR‑29a‑3p. Furthermore, SPARC overexpression increased the protein expression of phosphorylated (p)‑ERK, while transfection with miR‑29a‑3p mimics significantly inhibited this increase. The data suggested that EMT in the NA mouse model was associated with decreased levels of miR‑29a‑3p and elevated SPARC. Furthermore, SPARC could induce the formation of EMT in 16HBE cells in vitro and this was directly targeted by miR‑29a‑3p and mediated by p‑ERK, suggesting that miR‑29a‑3p may participate in the airway remodeling of NA.

View Figures

View References

1	Szefler SJ, Fitzgerald DA, Adachi Y, Doull IJ, Fischer GB, Fletcher M, Hong J, García-Marcos L, Pedersen S, Østrem A, et al: A worldwide charter for all children with asthma. Pediatr Pulmonol. 55:1282–1292. 2020. View Article : Google Scholar : PubMed/NCBI
2	Seys SF, Lokwani R, Simpson JL and Bullens DMA: New insights in neutrophilic asthma. Curr Opin Pulm Med. 25:113–120. 2019. View Article : Google Scholar
3	Gibson PG and Foster PS: Neutrophilic asthma: Welcome back! Eur Respir J. 54:19018462019.
4	Postma DS and Rabe KF: The asthma-COPD overlap syndrome. N Engl J Med. 373:1241–1249. 2015. View Article : Google Scholar
5	Jonas S and Izaurralde E: Towards a molecular understanding of microRNA-mediated gene silencing. Nat Rev Genet. 16:421–433. 2015. View Article : Google Scholar : PubMed/NCBI
6	Kwon JJ, Factora TD, Dey S and Kota J: A systematic review of miR-29 in cancer. Mol Ther Oncolytics. 12:173–194. 2018. View Article : Google Scholar
7	Gao Y, Qiao H, Lu Z and Hou Y: miR-29 promotes the proliferation of cultured rat neural stem/progenitor cells via the PTEN/AKT signaling pathway. Mol Med Rep. 20:2111–2118. 2019.PubMed/NCBI
8	Sohal SS, Ward C and Walters EH: Importance of epithelial mesenchymal transition (EMT) in COPD and asthma. Thorax. 69:7682014. View Article : Google Scholar : PubMed/NCBI
9	Haddad A, Gaudet M, Plesa M, Allakhverdi Z, Mogas AK, Audusseau S, Baglole CJ, Eidelman DH, Olivenstein R, Ludwig MS and Hamid Q: Neutrophils from severe asthmatic patients induce epithelial to mesenchymal transition in healthy bronchial epithelial cells. Respir Res. 20:2342019. View Article : Google Scholar : PubMed/NCBI
10	Wilson RH, Whitehead GS, Nakano H, Free ME, Kolls JK and Cook DN: Allergic sensitization through the airway primes Th17-dependent neutrophilia and airway hyperresponsiveness. Am J Respir Crit Care Med. 180:720–730. 2009. View Article : Google Scholar : PubMed/NCBI
11	Zhang X, Zhang M, Jiang M and Nong G: Effect of IL-7 on Th17 cell responses in a mouse model of neutrophilic asthma. Mol Med Rep. 22:1205–1112. 2020. View Article : Google Scholar : PubMed/NCBI
12	Hou C, Kong J, Liang Y, Huang H, Wen H, Zheng X, Wu L and Chen Y: HMGB1 contributes to allergen-induced airway remodeling in a murine model of chronic asthma by modulating airway inflammation and activating lung fibroblasts. Cell Mol Immunol. 12:409–423. 2015. View Article : Google Scholar :
13	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar
14	Xiao J, Meng XM, Huang XR, Chung AC, Feng YL, Hui DS, Yu CM, Sung JJ and Lan HY: miR-29 inhibits bleomycin-induced pulmonary fibrosis in mice. Mol Ther. 20:1251–1260. 2012. View Article : Google Scholar : PubMed/NCBI
15	Pavlek LR, Vudatala S, Bartlet CW, Buhimschi IA, Buhimschi CS and Rogers LK: miR-29b is associated with perinatal inflammation in extremely preterm infants. Pediatr Res. 89:889–893. 2021. View Article : Google Scholar
16	Chi Y, Di Q, Han G, Li M and Sun B: Mir-29b mediates the regulation of Nrf2 on airway epithelial remodeling and Th1/Th2 differentiation in COPD rats. Saudi J Biol Sci. 26:1915–1921. 2019. View Article : Google Scholar : PubMed/NCBI
17	Zhang Y, Shen B, Zhang D, Wang Y, Tang Z, Ni N, Jin X, Luo M, Sun H and Gu P: miR-29a regulates the proliferation and differentiation of retinal progenitors by targeting Rbm8a. Oncotarget. 8:31993–32008. 2017. View Article : Google Scholar : PubMed/NCBI
18	Pereira PA, Tomás JF, Queiroz JA, Figueiras AR and Sousa F: Recombinant pre-miR-29b for Alzheimer s disease therapeutics. Sci Rep. 6:199462016. View Article : Google Scholar
19	Fukata T, Mizushima T, Nishimura J, Okuzaki D, Wu X, Hirose H, Yokoyama Y, Kubota Y, Nagata K, Tsujimura N, et al: The supercarbonate apatite-MicroRNA complex inhibits dextran sodium sulfate-induced colitis. Mol Ther Nucleic Acids. 12:658–671. 2018. View Article : Google Scholar : PubMed/NCBI
20	He Y, Huang C, Lin X and Li J: MicroRNA-29 family, a crucial therapeutic target for fibrosis diseases. Biochimie. 95:1355–1359. 2013. View Article : Google Scholar : PubMed/NCBI
21	Cushing L, Kuang P and Lü J: The role of miR-29 in pulmonary fibrosis. Biochem Cell Biol. 93:109–118. 2015. View Article : Google Scholar
22	Li J, Cen B, Chen S and He Y: MicroRNA-29b inhibits TGF-β1-induced fibrosis via regulation of the TGF-β1/Smad pathway in primary human endometrial stromal cells. Mol Med Rep. 13:4229–4237. 2016. View Article : Google Scholar : PubMed/NCBI
23	Pain M, Bermudez O, Lacoste P, Royer PJ, Botturi K, Tissot A, Brouard S, Eickelberg O and Magnan A: Tissue remodelling in chronic bronchial diseases: From the epithelial to mesenchymal phenotype. Eur Respir Rev. 23:118–130. 2014. View Article : Google Scholar : PubMed/NCBI
24	Srivastava SP, Hedayat AF, Kanasaki K and Goodwin JE: microRNA crosstalk influences epithelial-to-mesenchymal, endothelial-to-mesenchymal, and macrophage-to-mesenchymal transitions in the kidney. Front Pharmacol. 10:9042019. View Article : Google Scholar : PubMed/NCBI
25	Krol J, Loedige I and Filipowicz W: The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet. 11:597–610. 2010. View Article : Google Scholar : PubMed/NCBI
26	Wong SL and Sukkar MB: The SPARC protein: An overview of its role in lung cancer and pulmonary fibrosis and its potential role in chronic airways disease. Br J Pharmacol. 174:3–14. 2017. View Article : Google Scholar :
27	Trombetta-Esilva J and Bradshaw AD: The function of SPARC as a mediator of fibrosis. Open Rheumatol J. 6:146–155. 2012. View Article : Google Scholar : PubMed/NCBI
28	Bradshaw AD: The role of secreted protein acidic and rich in cysteine (SPARC) in cardiac repair and fibrosis: Does expression of SPARC by macrophages influence outcomes? J Mol Cell Cardiol. 93:156–161. 2016. View Article : Google Scholar
29	Wang JC, Lai S, Guo X, Zhang X, de Crombrugghe B, Sonnylal S, Arnett FC and Zhou X: Attenuation of fibrosis in vitro and in vivo with SPARC siRNA. Arthritis Res Ther. 12:R602010. View Article : Google Scholar : PubMed/NCBI
30	Zhang F, Zhang Y, Da J, Jia Z, Wu H and Gu K: Downregulation of SPARC expression decreases cell migration and invasion involving epithelial-mesenchymal transition through the p-FAK/p-ERK pathway in esophageal squamous cell carcinoma. J Cancer. 11:414–420. 2020. View Article : Google Scholar : PubMed/NCBI
31	Sun W, Feng J, Yi Q, Xu X, Chen Y and Tang L: SPARC acts as a mediator of TGF-β1 in promoting epithelial-to-mesenchymal transition in A549 and H1299 lung cancer cells. Biofactors. 44:453–464. 2018. View Article : Google Scholar : PubMed/NCBI
32	Zhu J, Wang LY, Li CY, Wu JY, Zhang YT, Pang KP, Wei Y, Du LQ, Liu M and Wu XY: SPARC promotes self-renewal of limbal epithelial stem cells and ocular surface restoration through JNK and p38-MAPK signaling pathways. Stem Cells. 38:134–145. 2020. View Article : Google Scholar